Selected article for: "cell membrane and fusion peptide"
Author: Mitra, Prasenjit
Title: Inhibiting fusion with cellular membrane system: therapeutic options to prevent severe acute respiratory syndrome coronavirus-2 infection
  • Cord-id: ilkfu39s
  • Document date: 2020_9_1
    • ID: ilkfu39s
    Snippet: Severe acute respiratory syndrome coronavirus (SARS-CoV), an enveloped virus with a positive-sense single-stranded RNA genome, facilitates the host cell entry through intricate interactions with proteins and lipids of the cell membrane. The detailed molecular mechanism involves binding to the host cell receptor and fusion at the plasma membrane or after being trafficked to late endosomes under favorable environmental conditions. A crucial event in the process is the proteolytic cleavage of the v
    Document: Severe acute respiratory syndrome coronavirus (SARS-CoV), an enveloped virus with a positive-sense single-stranded RNA genome, facilitates the host cell entry through intricate interactions with proteins and lipids of the cell membrane. The detailed molecular mechanism involves binding to the host cell receptor and fusion at the plasma membrane or after being trafficked to late endosomes under favorable environmental conditions. A crucial event in the process is the proteolytic cleavage of the viral spike protein by the host’s endogenous proteases that releases the fusion peptide enabling fusion with the host cellular membrane system. The present review details the mechanism of viral fusion with the host and highlights the therapeutic options that prevent SARS-CoV-2 entry in humans.

    Search related documents:
    Co phrase search for related documents
    • abelson kinase and acute sars cov respiratory syndrome coronavirus: 1, 2
    • abelson kinase inhibitor and acute sars cov respiratory syndrome coronavirus: 1
    • acute lung injury and low pathogenic: 1, 2
    • acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lung microbiome: 1
    • acute lung injury and lung spread: 1, 2
    • acute lung injury protection and lung injury: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and low pathogenic: 1, 2
    • acute sars cov respiratory syndrome coronavirus and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and lung microbiome: 1, 2, 3, 4, 5, 6, 7, 8
    • acute sars cov respiratory syndrome coronavirus and lung spread: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute sars cov respiratory syndrome coronavirus and lysosomal protease: 1, 2, 3
    • low pathogenic and lung injury: 1, 2
    • lung injury and lysosomal protease: 1